Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 18,720 | 31,249 | 29,752 | 6,761 | 6,482 |
| Cost of Goods | 15,458 | 18,081 | 11,960 | 4,713 | 5,133 |
| Gross Profit | 3,262 | 13,168 | 17,792 | 2,048 | 1,349 |
| Operating Expenses | 145,652 | 110,606 | 108,606 | 92,484 | 52,394 |
| Operating Income | -141,932 | -97,357 | -89,854 | -89,723 | -50,912 |
| Other Income | 9,867 | 8,509 | 2,946 | -1,142 | -424 |
| Pre-tax Income | -132,065 | -88,848 | -86,908 | -90,865 | -51,336 |
| Income Tax | N/A | -367 | N/A | N/A | -182 |
| Net Income Continuous | -132,065 | -88,481 | -86,908 | -90,865 | -51,154 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 139 |
| Net Income | $-132,065 | $-88,481 | $-86,908 | $-90,865 | $-51,015 |
| EPS Basic Total Ops | -1.71 | -1.27 | -1.33 | -1.60 | -1.20 |
| EPS Basic Continuous Ops | -1.71 | -1.27 | -1.33 | -1.60 | -1.20 |
| EPS Diluted Total Ops | -1.71 | -1.27 | -1.33 | -1.60 | -1.20 |
| EPS Diluted Continuous Ops | -1.71 | -1.27 | -1.33 | -1.60 | -1.20 |
| EPS Diluted Before Non-Recurring Items | -0.80 | -1.55 | -1.33 | -1.60 | -1.20 |
| EBITDA(a) | $-141,125 | $-96,494 | $-89,057 | $-88,800 | $-49,588 |